NO962307L - N,N'-bis/2-hydroksybenzyl)etylendiamin-N,N'-dieddiksyre-derivater som chelateringsmidler - Google Patents

N,N'-bis/2-hydroksybenzyl)etylendiamin-N,N'-dieddiksyre-derivater som chelateringsmidler

Info

Publication number
NO962307L
NO962307L NO962307A NO962307A NO962307L NO 962307 L NO962307 L NO 962307L NO 962307 A NO962307 A NO 962307A NO 962307 A NO962307 A NO 962307A NO 962307 L NO962307 L NO 962307L
Authority
NO
Norway
Prior art keywords
alkyl
hydroxybenzyl
ethylenediamine
bis
diacetic acid
Prior art date
Application number
NO962307A
Other languages
English (en)
Other versions
NO962307D0 (no
Inventor
Fabrizio Gasparini
Thomas Leutert
David L Farley
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO962307D0 publication Critical patent/NO962307D0/no
Publication of NO962307L publication Critical patent/NO962307L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C07D317/40—Vinylene carbonate; Substituted vinylene carbonates

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det er beskrevet [N,N'-bis(2-hydroksyben2yl)etylendiamin-N,N'-dieddiksyre]derivater av formel (I) HO R-CH2-O-{CO) -^N^ ^*^OH d) hvori R betyr -(CO)-Ri, -O-(CO)-R2, -0-(CO)-O-R3 eller O hvori R! er-NR4R5 eller -.TV hvorved R4 og RS uavhengig av hverandre er Cj-C3-aIkyl eller C3-C7-cykloalkyl, eller danner sammen gruppen -(CH2)n-, hvor n er et helt tall fra 3 til 6; R2 er Ci-Cg-alkyl, usubstituert fenyl eller fenyl substituert med l til 4 substituenter valgt fra gruppen bestående av halogen og hydroksy; R3 er Ci-Cg-alkyl eller Cs-Cy-cykloalkyl; R4 er Ci-C3-alkyl; og salter derav, danner chelat-type metallkomplekser med treverdige metallioner, spesielt jem(III), og kan benyttes, f.eks. for behandling av patologiske tilstander i varmblodige dyr som er forbundet med forhøyelse av treverdige metallioner i kroppen.
NO962307A 1993-12-16 1996-06-04 N,N'-bis/2-hydroksybenzyl)etylendiamin-N,N'-dieddiksyre-derivater som chelateringsmidler NO962307L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93810886 1993-12-16
PCT/IB1994/000388 WO1995016663A1 (en) 1993-12-16 1994-12-05 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents

Publications (2)

Publication Number Publication Date
NO962307D0 NO962307D0 (no) 1996-06-04
NO962307L true NO962307L (no) 1996-06-04

Family

ID=8215091

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962307A NO962307L (no) 1993-12-16 1996-06-04 N,N'-bis/2-hydroksybenzyl)etylendiamin-N,N'-dieddiksyre-derivater som chelateringsmidler

Country Status (9)

Country Link
EP (1) EP0734374A1 (no)
JP (1) JPH09507473A (no)
CN (1) CN1137267A (no)
AU (1) AU1033495A (no)
CA (1) CA2179203A1 (no)
FI (1) FI962435A0 (no)
HU (1) HUT74457A (no)
NO (1) NO962307L (no)
WO (1) WO1995016663A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140305A (en) 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US7026116B1 (en) 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
AU2958397A (en) * 1996-05-21 1997-12-09 Novartis Ag N,n'-di(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
ATE462717T1 (de) 1997-06-13 2010-04-15 Bio Rad Laboratories Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind
FR2768145B1 (fr) * 1997-09-09 1999-10-08 Oreal Nouveaux composes derives d'acide alkylene diamine di- ou tri-acetique, leur procede de preparation, leur utilisation dans des compositions cosmetiques et pharmaceutiques, et compositions les comprenant
EP1052985B1 (en) * 1998-02-04 2004-12-22 University Of Florida Research Foundation, Inc. N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and sodium salts thereof for iron chelating therapy
AU2456201A (en) * 1999-12-21 2001-07-03 University Of Florida Research Foundation, Inc. N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy
CN109438517B (zh) * 2018-12-27 2021-01-08 北京久杰净化工程技术有限公司 一种与羰基金属核心配位的双功能连接剂的配合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528196A (en) * 1981-02-23 1985-07-09 The United States Of America As Represented By The Department Of Health And Human Services Chelating agents for the treatment of iron overload
EP0403243B1 (en) * 1989-06-16 1995-11-08 Merck Frosst Canada Inc. Chelate derivatives of atrial natriuretic factor (ANF)

Also Published As

Publication number Publication date
JPH09507473A (ja) 1997-07-29
CA2179203A1 (en) 1995-06-22
EP0734374A1 (en) 1996-10-02
FI962435A (fi) 1996-06-12
CN1137267A (zh) 1996-12-04
NO962307D0 (no) 1996-06-04
WO1995016663A1 (en) 1995-06-22
AU1033495A (en) 1995-07-03
HUT74457A (en) 1996-12-30
FI962435A0 (fi) 1996-06-12
HU9601658D0 (en) 1996-08-28

Similar Documents

Publication Publication Date Title
NO962307L (no) N,N'-bis/2-hydroksybenzyl)etylendiamin-N,N'-dieddiksyre-derivater som chelateringsmidler
AU6609681A (en) 2,4,6-triiodo-isophthalic acids
JPS55138372A (en) Purification of stevioside solution
SE7402101L (no)
AU3122484A (en) 4:-demethyl - 4 - epipodophyllotoxin derivatives
DE3266035D1 (en) Unsaturated aryl ketones as antiseborrhoeic additives for cosmetic compositions
IE822322L (en) Vicinal dihydroxyalkylxanthines
CA2421114A1 (en) 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
DK0396069T3 (da) Salte af azelastin med forbedret opløselighed
BG102932A (en) Creatine pyruvates and method for their preparation
ES8303279A1 (es) "procedimiento para preparar nuevos derivados de acidos fenil-alifatico-carboxilicos".
ES8606260A1 (es) Procedimiento para la obtencion de tioeteres alifaticos
AU1611583A (en) Alpha-alkyl polyolefinic carboxylic acids
AU579116B2 (en) Use of quinoline derivatives for the protection of cultivated plants
NO174152C (no) Analogifremgangsmåte for fremstilling av N-substituerte aminoalkandifosfonsyrer
IE801340L (en) Immunostimulant tripeptides
GB8506774D0 (en) Compounds bondable to tooth substrates
DE3462488D1 (en) Process for the preparation of diamino-alcohols
SE7706078L (sv) Forfarande for framstellning av bensotiazinforeningar
DE3579164D1 (de) Neue kohlensaeureester.
AU6613886A (en) Alpha-hydroxy thioethers
YU18199A (sh) Postupak za dobijanje hidroksamskih kiselina
FI880807A0 (fi) Anvaendningen av citronsyra -partialestrar och deras blandningar foer jaernextraktion.
JPS5636521A (en) Production of alkenyloxy group-containing organopolysiloxane
DE3463760D1 (en) Process for preparing hydroxy-3-methyl-3 glutaric acid